Key result
Higher total dietary flavonoid intake was associated with a lower risk of non-alcoholic fatty liver disease progression compared to the lowest intake quintile over 3 years.
Why the study?
Flavonoid-rich foods show benefits against NAFLD in short-term trials, but whether usual dietary flavonoid intake benefits patients with NAFLD was uncertain.
Does higher dietary flavonoid intake reduce the risk of NAFLD progression in adults?
Cohort (n=2,694)
Does higher dietary flavonoid intake reduce the risk of NAFLD progression in adults?
Higher habitual dietary intake of flavonoids is associated with a significantly lower risk of NAFLD progression in middle-aged and elderly Chinese adults, potentially mediated by improvements in insulin resistance and serum cholesterol.
Answers are grounded in this paper and cite their sources.
Higher flavonoid intake was associated with lower NAFLD progression risk; hypothesis-generating and requires RCTs before any practice change.
Flavonoid-rich foods have shown a beneficial effect against non-alcoholic fatty liver disease (NAFLD) in short-term randomised trials. It is uncertain whether the usual dietary intake of flavonoids may benefit patients with NAFLD. The present study evaluated the association between the usual intake of flavonoids and the risk of progression in NAFLD. The prospective study included 2694 adults from the Guangzhou Nutrition and Health Study. Face-to-face interviews using a seventy-nine-item FFQ were administered to assess habitual dietary flavonoid intake, while abdominal ultrasonography was conducted to evaluate the presence and degree of NAFLD, with measurements conducted 3 years apart. After adjustment for potential confounders, higher flavonoid intakes were gradely associated with reduced risks of worsen NAFLD status. The relative risks of worsening (v. non-worsening) NAFLD in the highest (v. lowest) quintile were 0·71 (95 % CI 0·54, 0·93) for total flavonoids, 0·74 (95 % CI 0·57, 0·95) for flavanones, 0·74 (95 % CI 0·56, 0·96) for flavan-3-ols, 0·90 (95 % CI 0·68, 1·18) for flavonols, 0·73 (95 % CI 0·56, 0·93) for flavones, 0·79 (95 % CI 0·61, 1·02) for isoflavones and 0·74 (95 % CI 0·57, 0·96) for anthocyanins. An L-shaped relationship was observed between total flavonoid intake and the risk of NAFLD progression. Path analyses showed that the association between flavonoids and NAFLD progression was mediated by decreases in serum cholesterol and homeostasis model assessment of insulin resistance. This prospective study showed that higher flavonoid intake was associated with a lower risk of NAFLD progression in the elderly overweight/obese Chinese population.
No takes yet. Share an insight, caveat, or question.
Zhong et al. (2020) conducted a cohort in Non-alcoholic fatty liver disease (NAFLD) (n=2,694). Higher dietary flavonoid intake vs. Lowest quintile of dietary flavonoid intake was evaluated on Progression (worsening) of NAFLD status (RR 0.71, 95% CI 0.54-0.93, p=0.012). Higher total dietary flavonoid intake was associated with a lower risk of non-alcoholic fatty liver disease progression compared to the lowest intake quintile over 3 years.
Synapse has enriched 10 related papers. Consider them for comparative context: